Literature DB >> 12752266

Human tissue kallikreins and testicular cancer.

Liu-Ying Luo1, George Yousef, Eleftherios P Diamandis.   

Abstract

Human tissue kallikreins are fifteen homologous genes encoding for secreted serine proteases and residing tandemly on chromosome 19q13.4. These enzymes are highly expressed in a variety of tissues and participate in diverse physiological processes. Human tissue kallikreins were found to be associated with several malignancies, especially endocrine-related cancers, including prostate, ovarian, breast and testicular cancer. In testicular germ cell tumors, some tissue kallikrein genes, including KLK5, KLK10, KLK13 and KLK14, were found to be significantly down-regulated. Tissue-specific splice variant forms of some kallikreins have been identified in the testis. In this paper, the expression of KLK5, KLK10, KLK13 and KLK14 in testicular cancer and their possible roles during testicular cancer development, as well as their clinical applications are briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752266     DOI: 10.1034/j.1600-0463.2003.11101261.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

1.  Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.

Authors:  Xiaocong Geng; Yueyang Liu; Tobias Dreyer; Holger Bronger; Enken Drecoll; Viktor Magdolen; Julia Dorn
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

2.  Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.

Authors:  Larissa Dettmar; Nancy Ahmed; Matthias Kotzsch; Sandra Diersch; Rudolf Napieralski; Dalila Darmoul; Manfred Schmitt; Wilko Weichert; Marion Kiechle; Julia Dorn; Viktor Magdolen
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-15       Impact factor: 4.553

3.  The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents.

Authors:  Dimitra Florou; Konstantinos Mavridis; Andreas Scorilas
Journal:  Tumour Biol       Date:  2012-09-05

4.  Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line.

Authors:  Jun Lu; Qin Shi; Lele Zhang; Jun Wu; Yuqing Lou; Jie Qian; Bo Zhang; Shuyuan Wang; Huimin Wang; Xiaodong Zhao; Baohui Han
Journal:  Front Oncol       Date:  2019-09-11       Impact factor: 6.244

5.  Cancer-related proteins in serum are altered in workers occupationally exposed to polycyclic aromatic hydrocarbons: a cross-sectional study.

Authors:  Ayman Alhamdow; Håkan Tinnerberg; Christian Lindh; Maria Albin; Karin Broberg
Journal:  Carcinogenesis       Date:  2019-07-06       Impact factor: 4.944

6.  Vaspin inhibits kallikrein 7 by serpin mechanism.

Authors:  John T Heiker; Nora Klöting; Peter Kovacs; E Bartholomeus Kuettner; Norbert Sträter; Stephan Schultz; Matthias Kern; Michael Stumvoll; Matthias Blüher; Annette G Beck-Sickinger
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

Review 7.  Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.

Authors:  Manfred Schmitt; Viktor Magdolen; Feng Yang; Marion Kiechle; Jane Bayani; George M Yousef; Andreas Scorilas; Eleftherios P Diamandis; Julia Dorn
Journal:  Radiol Oncol       Date:  2013-10-08       Impact factor: 2.991

8.  The structural network of Interleukin-10 and its implications in inflammation and cancer.

Authors:  Ece Saliha Acuner-Ozbabacan; Billur Hatice Engin; Emine Guven-Maiorov; Guray Kuzu; Serena Muratcioglu; Alper Baspinar; Zhong Chen; Carter Van Waes; Attila Gursoy; Ozlem Keskin; Ruth Nussinov
Journal:  BMC Genomics       Date:  2014-05-20       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.